Common Contracts
8 similar Note Purchase Agreement contracts by Cyclo Therapeutics, Inc.
FIFTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • November 8th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS FIFTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of November 7, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
FOURTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • October 8th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS FOURTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of October 8, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • September 9th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of September 9, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of August 21, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of August 21, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • July 17th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of July 16, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • June 11th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of June 11, 2024 (the “Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • June 11th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of June 11, 2024 (the “Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
